Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Halpin Michael	2. Date of Event Requiring Statement (MM/DD/YYYY) 6/15/2019	3. Issuer Name and Ticker or Trading Symbol Vericel Corp [VCEL]
(Last)        (First)        (Middle) C/O VERICEL CORPORATION, 64 SIDNEY STREET	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                            _____ 10% Owner ___ X ___ Officer (give title below)          _____ Other (specify below) Chief Operating Officer /
(Street) CAMBRIDGE, MA 02139        (City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	644	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	5/6/2019   (1)	2/6/2029	Common Stock	9678	$16.66	D
Stock Option (right to buy)	5/7/2018   (2)	2/7/2028	Common Stock	22198	$7.20	D
Stock Option (right to buy)	5/6/2019   (1)	2/6/2029	Common Stock	66572	$16.66	D
Stock Option (right to buy)	5/7/2018   (2)	2/7/2028	Common Stock	13132	$7.20	D
Stock Option (right to buy)	4/10/2018   (3)	4/10/2027	Common Stock	92110	$2.65	D
Stock Option (right to buy)	4/10/2018   (3)	4/10/2027	Common Stock	2890	$2.65	D
Restricted Stock Unit	(5)	(6)	Common Stock	7500	(4)	D

Explanation of Responses:
(1)	These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
(2)	These options shall begin vesting on February 7, 2018 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
(3)	These options vest 25% on the first anniversary of the date of grant and 75% vesting in equal monthly installments over three years thereafter.
(4)	Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
(5)	These RSUs vest in four annual installments with 1,875 RSUs vesting on February 6, 2020, February 6, 2021, February 6, 2022, and February 6, 2023, respectively.
(6)	No expiration date for this type of award.

Remarks: Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Halpin Michael C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE, MA 02139			Chief Operating Officer

Signatures
/s/ Michael Halpin		6/18/2019
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.